At present, HDAC11 has been found to be associated with poor prognosis in the liver, lung, ovarian, glioma, uveal melanoma, and other cancers (Yanginlar and Logie, 2018; ; Liu et al., 2020b; Bi et al., 2021). This evidence concerns the gene HDAC11 and central nervous system cancer.